Skip to main content
. 2016 Dec 26;2016:9354680. doi: 10.1155/2016/9354680

Table 1.

Characteristics of the patients and tumours.

Variable Category Number (%)
Sex Male 38 (43.7)
Female 49 (56.3)

Median age (range) 58.0 ± 11.1 (27–81)

Smoking Current smoker 66 (75.9)
Never smoked 21 (24.1)

Radiological finding Pure GGO 19 (21.8)
Mixed GGO 51 (58.6)
Pure solid nodule 17 (19.6)

CEA ≤5 ng/mL 74 (85.1)
>5 ng/mL 13 (14.9)

Serum miR-183 ≤1.0 (2−ΔΔCt) 43 (49.4)
>1.0 (2−ΔΔCt) 44 (50.6)

Tumour size ≤10 mm 42 (48.3)
>10 to ≤20 mm 30 (34.5)
>21 to ≤30 mm 15 (17.2)

Nodule number Single 82 (94.3)
Multiple 5 (5.7)

Predominant subtype AIS 19 (21.8)
MIA 22 (25.3)
Lepidic-predominant IAC 11 (12.7)
Papillary-predominant IAC 23 (26.4)
Acinar-predominant IAC 9 (10.3)
Solid-predominant IAC 2 (2.3)
Invasive mucinous IAC 1 (1.2)

Lymph node metastasis Present 4 (4.6)

Visceral pleural invasion Present 9 (10.3)

Pathological stage 0 5 (5.7)
I 76 (87.4)
II 4 (4.6)
III 2 (2.3)

CEA, carcinoembryonic antigen; GGO, ground-glass opacity; AIS, adenocarcinoma in situ; MIA, minimally invasive adenocarcinoma; IAC, invasive adenocarcinoma.